A Human Phase 0, Microdose Drug-Drug Interaction Study With [14C]-GSK706769 and Ketoconazole in Healthy Male Volunteers.
Phase of Trial: Phase I
Latest Information Update: 29 Jun 2017
At a glance
- Drugs GSK 706769 (Primary) ; Ketoconazole
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 02 Feb 2010 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.
- 02 Feb 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 15 Sep 2009 New trial record